Influence of lymph node removal on the prognosis of high malignancy potential gastric gastrointestinal stromal tumors: Insights from population-based study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0314504 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Zhenguo Qiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, SEER Program, Stomach Neoplasms, Lymph Node Excision. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Suzhou, Key Laboratory in Science and Technology Development Project of Suzhou.
Abstract (Originalsprache)
High malignancy potential gastric gastrointestinal stromal tumors (HMP-gGISTs) generally require surgical resection. However, the necessity of lymph node removal (LR) for patients with such tumors remains unclear. Therefore, we conducted a population-based study to analyze the impact of LR on the long-term prognosis of patients with HMP-gGISTs. Patients with HMP-gGISTs were gathered from the Surveillance, Epidemiology, and End Results (SEER) database. Propensity score matching (PSM) was utilized to address potential selection bias. Overall survival (OS) and cancer-specific survival (CSS) were evaluated using Kaplan-Meier analyses and multivariate Cox proportional hazards models. A total of 840 patients with HMP-gGISTs were included in the study, with 317 undergoing LR and 523 not undergoing LR. The prognosis for OS ( P = 0.026) and CSS ( P < 0.001) in the LR group was worse compared to the No-LR group. After PSM, 634 patients were matched for comparison. The results showed that the OS ( P = 0.028) and CSS ( P = 0.006) in the LR group remained poorer than those in the No-LR group. Subgroup analysis further indicated that patients who did not undergo LR had a better prognosis. Our findings suggest that LR may not improve the prognosis of patients with HMP-gGISTs, implying that LR may not be necessary for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
- Department of General Surgery, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
- Department of Traditional Chinese Medicine, Wujiang Fifth People's Hospital, Suzhou, China.
- Department of Cardiology, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
ORCID-Profile: Zhenguo Qiao, Lingxia Yang
Förderung
- Science and Technology Program of Suzhou
- Key Laboratory in Science and Technology Development Project of Suzhou
Zitieren
APA
Qiao, Z., Zhang, Z., Chen, J., Yin, P., Ling, X., Chen, W., & Yang, L. (2024). Influence of lymph node removal on the prognosis of high malignancy potential gastric gastrointestinal stromal tumors: Insights from population-based study. PLOS ONE. https://doi.org/10.1371/journal.pone.0314504
Vancouver
Qiao Z, Zhang Z, Chen J, Yin P, Ling X, Chen W, et al. Influence of lymph node removal on the prognosis of high malignancy potential gastric gastrointestinal stromal tumors: Insights from population-based study. PLOS ONE. 2024. doi:10.1371/journal.pone.0314504
BibTeX
@article{Qiao2024,
author = {Qiao, Zhenguo and Zhang, Zhi and Chen, Junjie and Yin, Ping and Ling, Xin and Chen, Weihai and Yang, Lingxia},
title = {Influence of lymph node removal on the prognosis of high malignancy potential gastric gastrointestinal stromal tumors: Insights from population-based study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0314504}
}
EUVIMED